<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>BACKGROUND: <z:hpo ids='HP_0001297'>Stroke</z:hpo>-induced <z:hpo ids='HP_0002181'>brain edema</z:hpo> formation is a frequent cause of secondary <z:mpath ids='MPATH_124'>infarct</z:mpath> growth and deterioration of neurological function </plain></SENT>
<SENT sid="1" pm="."><plain>The molecular mechanisms underlying <z:hpo ids='HP_0000969'>edema</z:hpo> formation after <z:hpo ids='HP_0001297'>stroke</z:hpo> are largely unknown </plain></SENT>
<SENT sid="2" pm="."><plain><z:chebi fb="1" ids="35620">Vasodilator</z:chebi>-stimulated phosphoprotein (VASP) is an important regulator of actin dynamics and stabilizes endothelial barriers through interaction with cell-cell contacts and focal <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> sites </plain></SENT>
<SENT sid="3" pm="."><plain><z:mp ids='MP_0005039'>Hypoxia</z:mp> has been shown to foster vascular leakage by downregulation of VASP in vitro but the significance of VASP for regulating vascular permeability in the hypoxic brain in vivo awaits clarification </plain></SENT>
<SENT sid="4" pm="."><plain>METHODOLOGY/PRINCIPAL FINDINGS: Focal <z:hpo ids='HP_0002637'>cerebral ischemia</z:hpo> was induced in Vasp(-/-) mice and <z:mp ids='MP_0002169'>wild-type</z:mp> (WT) littermates by transient middle cerebral <z:mp ids='MP_0006134'>artery occlusion</z:mp> (tMCAO) </plain></SENT>
<SENT sid="5" pm="."><plain>Evan's Blue tracer was applied to visualize the extent of blood-brain-barrier (<z:chebi fb="2" ids="33602">BBB</z:chebi>) damage </plain></SENT>
<SENT sid="6" pm="."><plain><z:hpo ids='HP_0002181'>Brain edema</z:hpo> formation and <z:mpath ids='MPATH_124'>infarct</z:mpath> volumes were calculated from 2,3,5-triphenyltetrazolium <z:chebi fb="76" ids="17996">chloride</z:chebi> (TTC)-stained brain slices </plain></SENT>
<SENT sid="7" pm="."><plain>Both mouse groups were carefully controlled for anatomical and physiological parameters relevant for <z:hpo ids='HP_0000969'>edema</z:hpo> formation and <z:hpo ids='HP_0001297'>stroke</z:hpo> outcome </plain></SENT>
<SENT sid="8" pm="."><plain><z:chebi fb="2" ids="33602">BBB</z:chebi> damage (p&lt;0.05) and <z:hpo ids='HP_0000969'>edema</z:hpo> volumes (1.7 mm(3)±0.5 mm(3) versus 0.8 mm(3)±0.4 mm(3); p&lt;0.0001) were significantly enhanced in Vasp(-/-) mice compared to controls on day 1 after tMCAO </plain></SENT>
<SENT sid="9" pm="."><plain>This was accompanied by a significant increase in <z:mpath ids='MPATH_124'>infarct</z:mpath> size (56.1 mm(3)±17.3 mm(3) versus 39.3 mm(3)±10.7 mm(3), respectively; p&lt;0.01) and a non significant trend (p&gt;0.05) towards worse neurological outcomes </plain></SENT>
<SENT sid="10" pm="."><plain>CONCLUSION: Our study identifies VASP as critical regulator of <z:chebi fb="2" ids="33602">BBB</z:chebi> maintenance during <z:hpo ids='HP_0011009'>acute</z:hpo> <z:hpo ids='HP_0002140'>ischemic stroke</z:hpo> </plain></SENT>
<SENT sid="11" pm="."><plain>Therapeutic modulation of VASP or VASP-dependent signalling pathways could become a novel strategy to combat excessive <z:hpo ids='HP_0000969'>edema</z:hpo> formation in ischemic brain damage </plain></SENT>
</text></document>